Suppr超能文献

138例药物性肝损伤的临床与病理特征

[Clinical and pathological features in 138 cases of drug-induced liver injury].

作者信息

Lai Rong-tao, Wang Hui, Gui Hong-lian, Ye Min-zhen, Dai Wei-jia, Xiang Xiao-gang, Zhao Gang-de, Wang Wei-jing, Xie Qing

机构信息

Department of Infection, Shanghai Jiaotong University School of Medicine, Shanghai, China.

出版信息

Zhonghua Gan Zang Bing Za Zhi. 2012 Mar;20(3):185-9. doi: 10.3760/cma.j.issn.1007-3418.2012.03.009.

Abstract

OBJECTIVE

To explore the categories of drugs causing hepatotoxicity and analyze the clinical and histological features of the corresponding drug-induced liver injury (DILI), in order to gain insights into potential diagnostic factors for DILI.

METHODS

A total of 138 DILI patients treated at our hospital from April 2008 to April 2010 were retrospectively analyzed. The responsible drug for each DILI case was recorded. The Roussel Uclaf Causality Assessment Method (RUCAM) had been used to diagnose DILI. Only cases that had scored as highly probable or probable (more than or equal to 6 points by RUCAM) were included in this study. The patients' general condition, clinical manifestations, and serum biochemical and immunological parameters were assessed. Sixty-six of the patients underwent liver biopsy, and were assessed for liver pathological changes. Clinical and laboratory test data were collected and used to classify the total 138 cases as hepatocellular injury, cholestatic, or mixed hepatocellular-cholestatic types.

RESULTS

Within our patient population, the leading cause of DILI was Chinese herb medicine, accounting for 53.62% of cases. Antibiotics were implicated in 7.97% of cases, and dietary supplement in 6.52% of cases. Correlation between the clinical features and histological injury pattern was stronger at the time of biopsy (more than or equal to 3 days after laboratory results) (kappa = 0.63, P less than 0.05) than at the onset of DILI (kappa = 0.25, P less than 0.05). All modified hepatic activity index (HAI) necroinflammatory scores and fibrosis scores were more severe in the cholestatic and mixed injury types than in the hepatocellular injury type (P less than 0.01 and P less than 0.05, respectively).

CONCLUSION

Chinese herbal medicine, dietary supplements and antibiotics were the main causes of DILI in our patient population. The clinical and histological features correlated well, especially at later stages of DILI. The degree of inflammation and fibrosis was significantly higher in cholestatic and mixed hepatocellular-cholestatic injury types than in the hepatocellular injury type. Assessment of both clinical and pathological features may represent a more accurate diagnostic method for DILI.

摘要

目的

探讨引起肝毒性的药物类别,分析相应药物性肝损伤(DILI)的临床及组织学特征,以深入了解DILI的潜在诊断因素。

方法

回顾性分析2008年4月至2010年4月在我院治疗的138例DILI患者。记录每例DILI病例的致病药物。采用鲁塞尔·优克福因果关系评估法(RUCAM)诊断DILI。本研究仅纳入评分高度可能或可能(RUCAM评分大于或等于6分)的病例。评估患者的一般状况、临床表现以及血清生化和免疫参数。66例患者接受了肝活检,并评估肝脏病理变化。收集临床和实验室检查数据,将138例病例分为肝细胞损伤型、胆汁淤积型或混合型肝细胞 - 胆汁淤积型。

结果

在我们的患者群体中,DILI的主要原因是中草药,占病例的53.62%。抗生素占病例的7.97%,膳食补充剂占病例的6.52%。活检时(实验室结果后大于或等于3天)临床特征与组织学损伤模式之间的相关性(kappa = 0.63,P < 0.05)比DILI发病时(kappa = 0.25,P < 0.05)更强。胆汁淤积型和混合型损伤类型的所有改良肝活动指数(HAI)坏死炎症评分和纤维化评分均比肝细胞损伤型更严重(分别为P < 0.01和P < 0.05)。

结论

中草药、膳食补充剂和抗生素是我们患者群体中DILI的主要原因。临床和组织学特征相关性良好,尤其是在DILI后期。胆汁淤积型和混合型肝细胞 - 胆汁淤积型损伤类型的炎症和纤维化程度明显高于肝细胞损伤型。临床和病理特征评估可能是DILI更准确的诊断方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验